Differences in regional and subcellular localization of Gq/11 and RGS4 protein levels in Alzheimer's disease: Correlation with muscarinic M1 receptor binding parameters
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Deficits in M1 muscarinic receptor system signaling in Alzheimer's disease (AD) prompted an analysis of components of these systems, namely, the G q/11 protein and the regulator of G‐protein signaling (RGS) 4 protein. In AD parietal cortex, total levels of G q/11 and RGS4 proteins were significantly lower than age‐matched control cases by 40% and 53%, respectively. However, the levels of membrane‐bound G q/11 and RGS4 protein in AD parietal cortex were maintained at levels comparable to controls. Furthermore, in the frontal cortex and cerebellum both the total and membrane levels of G q/11 and RGS4 protein were not altered in AD cases compared to control cases. To our knowledge, this is the first report to examine RGS proteins in AD. Using receptor binding assays on the parietal cortex membrane fractions from AD cases, we found the muscarinic agonist carbachol still bound to high‐ and low‐affinity sites (two‐site fit) and the potency of 5‐guanylylimidodiphosphate (GppNHp) to shift receptors from the high‐ to low‐affinity state (based on the ternary complex model) was greater in AD cases compared to controls. In contrast, we previously reported a lack of high‐affinity agonist binding sites in the frontal cortex in AD cases even in the absence of GppNHp. The data suggest that the equilibrium dynamics between the cytosolic and membrane levels of G q/11 and RGS4 may contribute to the regional differences in the coupling of muscarinic M1 receptors in AD and have implications for the variability in effects of cholingeric treatment strategies currently in place. Synapse 47:58–65, 2003. © 2002 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia
Mirnics, K., Middleton, F. A., Stanwood, G. D., Lewis, D. A., & Levitt, P. (2001) · Molecular Psychiatry · doi:10.1038/sj.mp.4000866 · Cited by 446 · cited 2×
“frontal cortex in schizophrenics (Mirnics et al., 2001), to our knowledge, this is the first report to describe an”
ResultSerotonin 5-HT2a and 5-HT2c Receptors Stimulate Amyloid Precursor Protein Ectodomain Secretion
Nitsch, R. M., Deng, M., Growdon, J. H., & Wurtman, R. J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.8.4188 · Cited by 219 · cited 1×
“M1 muscarinic and 5-HT2 receptors coupled through Gq/11 stimulate non-amyloidogenic processing of APP via the -secretase pathway (Nitsch et al., 1996; Muller et al., 1998; Muller et al., 1998; Muller et al., 1997).”
BackgroundPharmacological drug treatment of Alzheimer disease: The cholinergic hypothesis revisited
Ladner, C. J., & Lee, J. M. (1998) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199808000-00001 · Cited by 142
Self-citation
Cited by
Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
Harrison, P. J., & Weinberger, D. R. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001558 · Cited by 2,020
Pacey, L. K. K., Heximer, S. P., & Hampson, D. R. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.056127 · Cited by 133
“play a role in a number of disease states (Muma et al., 2003; Riddle et al., 2005; Liu et al., 2006).”
BackgroundPotter, P. E., Rauschkolb, P. K., Pandya, Y., Sue, L. I., Sabbagh, M. N., Walker, D. G., & Beach, T. G. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0831-1 · Cited by 94
“tion are reportedly decreased or impaired in AD [26, 34, 59, 80, 81, 84, 85].”
Kalirin is Under-Expressed in Alzheimer's Disease Hippocampus
Youn, H., Jeoung, M., Koo, Y., Ji, H., Markesbery, W. R., Ji, I., & Ji, T. H. (2007) · Journal of Alzheimer's Disease · doi:10.3233/jad-2007-11314 · Cited by 77
Metadata
- Authors
- Muma, N. A., Mariyappa, R., Williams, K., & Lee, J. M.
- Venue
- Synapse
- Publisher
- Wiley
- Published
- 2002-11
- Volume
- 47
- Issue
- 1
- Pages
- 58-65
- ISSN
- 0887-4476 (ISSN-L)
- 1098-2396
- OpenAlex
- W2049336376
- Cited by
- 42
- References
- 3
- FWCI
- 1.19
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Differences in regional and subcellular localization of Gq/11 and RGS4 protein levels in Alzheimer's disease: Correlation with muscarinic M1 receptor binding parameters. https://app.cochat.ai/papers/10.1002/syn.10153
- The paper
- Muma, N. A., Mariyappa, R., Williams, K., & Lee, J. M. (2003). Differences in regional and subcellular localization of Gq/11 and RGS4 protein levels in Alzheimer's disease: Correlation with muscarinic M1 receptor binding parameters. Synapse. https://doi.org/10.1002/syn.10153
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.